SGPL1 and Netherton syndrome: Increased ceramide levels in podocytes from aCDase-knockout mice [44] and in steroid-resistant NS patients with mutations of SGPL1 [83,84] led to foot process effacement (FPE) indicative of NS and focal segmental glomerulosclerosis (FSGS).